{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:46:47Z","timestamp":1751521607699,"version":"3.37.3"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline Plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.rmed.2022.106851","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T05:57:02Z","timestamp":1649829422000},"page":"106851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Difference in survival between COPD patients with an impaired immune reaction versus an adequate immune reaction to seasonal influenza vaccination: The COMIC study"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1781-5794","authenticated-orcid":false,"given":"M.","family":"Brusse-Keizer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Citgez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zuur-Telgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.A.M.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6948-6123","authenticated-orcid":false,"given":"G.","family":"Rijkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7987-0735","authenticated-orcid":false,"given":"P.D.L.P.M.","family":"VanderValk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-6769","authenticated-orcid":false,"given":"J.","family":"van der Palen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2022.106851_bib2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"9691","key":"10.1016\/j.rmed.2022.106851_bib3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0140-6736(09)61301-5","article-title":"Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index","volume":"374","author":"Puhan","year":"2009","journal-title":"Lancet (London, England)"},{"issue":"10","key":"10.1016\/j.rmed.2022.106851_bib4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.201110-1792OC","article-title":"Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease","volume":"185","author":"Celli","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"22","key":"10.1016\/j.rmed.2022.106851_bib5","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1001\/jama.2013.5732","article-title":"Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease","volume":"309","author":"Thomsen","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.rmed.2022.106851_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-2600(13)70006-7","article-title":"The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study","volume":"1","author":"Coxson","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2022.106851_bib7","first-page":"23","article-title":"Plasma fibrinogen as a biomarker for mortality and hospitalized exacerbations in people with COPD","volume":"2","author":"Mannino","year":"2015","journal-title":"Chronic Obstr. Pulm. Dis. (Miami, Fla)"},{"key":"10.1016\/j.rmed.2022.106851_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2015.02.013","article-title":"Adrenomedullin optimises mortality prediction in COPD patients","author":"Brusse-Keizer","year":"2015","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2022.106851_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-017-0597-7","article-title":"Multiple biomarkers predict disease severity, progression and mortality in COPD","author":"Zemans","year":"2017","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.rmed.2022.106851_bib10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/resp.13032","article-title":"The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD","volume":"22","author":"Leung","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2022.106851_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.rmed.2017.10.016","article-title":"Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease","volume":"132","author":"Berger","year":"2017","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2022.106851_bib12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.rmed.2022.106851_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/thx.2008.106286","article-title":"Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD","volume":"64","author":"Schembri","year":"2009","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.rmed.2022.106851_bib14","article-title":"Influenza vaccine for chronic obstructive pulmonary disease (COPD)","volume":"2018","author":"Kopsaftis","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2022.106851_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.chest.2018.10.044","article-title":"Effectiveness of influenza vaccination on hospitalizations and risk factors for severe outcomes in hospitalized patients with COPD","volume":"155","author":"Mulpuru","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2022.106851_bib16","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.jaci.2017.07.038","article-title":"Impaired humoral and cellular immune responses to influenza vaccination in chronic obstructive pulmonary disease patients","volume":"140","author":"Parpaleix","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2022.106851_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/COPD.S53590","article-title":"Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease","volume":"9","author":"Nath","year":"2013","journal-title":"Int. J. COPD"},{"key":"10.1016\/j.rmed.2022.106851_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.rmed.2016.04.008","article-title":"Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients","volume":"115","author":"Eagan","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2022.106851_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2018.02.006","article-title":"Stable-state midrange proadrenomedullin is associated with severe exacerbations in COPD","author":"Citgez","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2022.106851_bib20","first-page":"1","article-title":"Predicting mortality in COPD with validated and sensitive biomarkers; fibrinogen and mid-range-proadrenomedullin (MR-proADM)","author":"Zuur-Telgen","year":"2021","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.rmed.2022.106851_bib21","article-title":"Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study","volume":"3","author":"Citgez","year":"2016","journal-title":"BMJ Open Respir Res."},{"issue":"4","key":"10.1016\/j.rmed.2022.106851_bib22","article-title":"The influence of type of inhalation device on adherence of COPD patients to inhaled medication","volume":"13","author":"Koehorst-Ter Huurne","year":"2016","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.rmed.2022.106851_bib23","article-title":"Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related","author":"Koehorst-Ter Huurne","year":"2016","journal-title":"Int. J. COPD"},{"issue":"1","key":"10.1016\/j.rmed.2022.106851_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/15412555.2016.1206875","article-title":"Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD","volume":"14","author":"Brusse-Keizer","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2022.106851_bib25","article-title":"Differences in adherence to common inhaled medications in COPD","author":"Koehorst-ter Huurne","year":"2015","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.rmed.2022.106851_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/irv.12351","article-title":"A review of the changes to the licensing of influenza vaccines in Europe","volume":"10","author":"Wijnans","year":"2016","journal-title":"Influenza Other Respi. Viruses"},{"issue":"12","key":"10.1016\/j.rmed.2022.106851_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080034","article-title":"Mechanisms of hemagglutinin targeted influenza virus neutralization","volume":"8","author":"Brandenburg","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.rmed.2022.106851_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1586\/14760584.2016.1164046","article-title":"Influenza immunology evaluation and correlates of protection: a focus on vaccines","volume":"15","author":"Trombetta","year":"2016","journal-title":"Expert Rev. Vaccines"},{"issue":"4","key":"10.1016\/j.rmed.2022.106851_bib30","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J. Hyg."},{"issue":"6","key":"10.1016\/j.rmed.2022.106851_bib31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2022.106851_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.rmed.2022.106851_bib33","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2022.106851_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0153310","article-title":"Lifetime smoking history and cause-specific mortality in a cohort study with 43 years of Follow-up","volume":"11","author":"Taghizadeh","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.rmed.2022.106851_bib35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.93.3.580","article-title":"Evaluation of clinical methods for rating dyspnea","volume":"93","author":"Mahler","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2022.106851_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7525-1-13","article-title":"Development, validity and responsiveness of the clinical COPD questionnaire","volume":"1","author":"van der Molen","year":"2003","journal-title":"Health Qual. Life Outcome"},{"issue":"6","key":"10.1016\/j.rmed.2022.106851_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002152","article-title":"Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts","volume":"2","author":"Puhan","year":"2012","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.rmed.2022.106851_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1378\/chest.124.2.459","article-title":"Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD","volume":"124","author":"Groenewegen","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rmed.2022.106851_bib39","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.121.5.1441","article-title":"Mortality after hospitalization for COPD","volume":"121","author":"Almagro","year":"2002","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2022.106851_bib40","first-page":"CD002733","article-title":"Influenza vaccine for chronic obstructive pulmonary disease (COPD)","volume":"6","author":"Kopsaftis","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.rmed.2022.106851_bib41","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/v13061109","article-title":"The nature of immune responses to influenza vaccination in high-risk populations","volume":"13","author":"Wiggins","year":"2021","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.rmed.2022.106851_bib42","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.rmed.2022.106851_bib43","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.vaccine.2017.03.092","article-title":"Efficacy and safety of high-dose influenza vaccine in elderly adults: a systematic review and meta-analysis","volume":"35","author":"Wilkinson","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.rmed.2022.106851_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/infdis\/134.1.48","article-title":"Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans","volume":"134","author":"Webster","year":"1976","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.rmed.2022.106851_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.clicom.2021.10.001","article-title":"The \u201coriginal antigenic sin\u201d and its relevance for SARS-CoV-2 (COVID-19) vaccination","volume":"1","author":"Rijkers","year":"2021","journal-title":"Clin Immunol Commun"},{"issue":"5","key":"10.1016\/j.rmed.2022.106851_bib46","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","article-title":"Original antigenic sin responses to influenza viruses","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611122001160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611122001160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T01:15:40Z","timestamp":1717290940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611122001160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":44,"alternative-id":["S0954611122001160"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2022.106851","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Difference in survival between COPD patients with an impaired immune reaction versus an adequate immune reaction to seasonal influenza vaccination: The COMIC study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2022.106851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106851"}}